PCR Spotlight: STEMI management in the context of Covid-19: Thrombolysis

Can thrombolysis be an alternative option for STEMI In the context of COVID-19?

Interventional Cardiologists Andreas Baumbach, London, UK, Giulio Stefanini, Milan, Italy, and Charles Kyriakakis, Cape Town, South Africa, discuss the use of thrombolysis as an alternative option for STEMI during the Covid-19 crisis

Take-home messages:

  • When? If PPCI cannot be achieved in 120 minutes
  • Who? Patients with typical STEMI and no contraindications
  • How? Fibrin specific agents as bolus, enoxaparin

Speakers

Prof. Andreas Baumbach

Interventional cardiologist / Cardiologist

Saint Bartholomew's Hospital - London, United Kingdom

Giulio Stefanini

Interventional cardiologist / Cardiologist

Humanitas Research Hospital - Milano, Italy

Charles Kyriakakis

Interventional cardiologist / Cardiologist

Life Vincent Pallotti Hospital - Cape Town, South Africa

This video was recorded on 13 April 2020.

The content of this page reflects the view of the authors at a given point in time and does not necessarily represent the view of PCR or PCRonline.

 

Join the discussion

No comments yet!